Minretumomab (CC-49) is a mouse monoclonal antibody targeting TAG-72 (tumour-associated glycoprotein 72), optimised from the B72.3 antibody, and can be used for research into breast cancer, colon cancer, lung cancer, and pancreatic cancer.
Purity:
99.14%
CAS Number:
[195189-17-4]
Target:
Mucin
* VAT and and shipping costs not included. Errors and price changes excepted
